CUSIP 75629V104CL ARXRXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
328 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 47.19M | $193.00M | +7.41M | Added |
| 2 | Blackrock, Inc. | 38.87M | $158.97M | +7.13M | Added |
| 3 | Ark Investment Management LLC | 37.32M | $152.63M | +3.77M | Added |
| 4 | State Street Corp | 25.33M | $103.62M |
| Added |
| 5 | Baillie Gifford & Co | 23.77M | $97.24M | −203.7K | Reduced |
| 6 | Softbank Group Corp. | 13.64M | $55.77M | −1.03M | Reduced |
| 7 | Geode Capital Management, LLC | 10.93M | $44.73M | +1.31M | Added |
| 8 | Mic Capital Management Uk LLP | 9.64M | $39.44M | 0 | Held |
| 9 | Sumitomo Mitsui Trust Group, Inc. | 6.22M | $25.44M | −1.24M | Reduced |
| 10 | Amova Asset Management Americas, Inc. | 6.22M | $25.38M | −1.24M | Reduced |
See every fund holding Recursion Pharmaceuticals In, with full quarter-over-quarter share changes.
Unlock all holders